NASDAQ
Actavia Life Sciences, Inc. (RASP) has a price/fcf ratio of -1357.48x as of Tuesday, May 26, 2026. This represents a 3546.06% decrease compared to its 12-month average of -37.23x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.